12th March 2024
AHFS Drug Information
This update contains 5 new monographs, 28 revised monographs, 10…
Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs.
Close
Close
Contact our team to see how our services can directly help you.
Close
Learn how treatment guidance from Palliative Care Formulary can support health professionals to manage cancer-related neuropathic pain.
Close
The latest new drugs and significant changes to medicines information on MedicinesComplete - monthly.
Close
Read why excipients expert Chris Moreton has enjoyed contributing for the last 30 years.
Close
Published by the American Society of Health-System Pharmacists (ASHP), AHFS Drug Information is a dependable, comprehensive, and objective database for drug products approved by the FDA.
The American Hospital Formulary Service (AHFS) drug information database is maintained and updated continuously throughout the year.
The inclusion of evidence-based data on licensed and unlicensed drug use makes this a valuable reference for health professionals seeking to provide their patients with safe and effective therapy.
Our knowledge products are regularly updated online through MedicinesComplete
12th March 2024
This update contains 5 new monographs, 28 revised monographs, 10…
12th March 2024
This update contains 5 new monographs, 28 revised monographs, 10 discontinued monographs and 2 new MedWatch alerts.
New monographs: Chikungunya Vaccine Live; Eplontersen Sodium; Exagamglogene Autotemcel; Lovotibeglogene autotemcel; Sotagliflozin.
Revised monographs: Aducanumab; Atogepant; Belumosudil Mesylate; Crizotinib; Deferasirox; Denosumab; Difelikefalin Acetate; Elacestrant Hydrochloride; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate; Emapalumab; Etravirine; Filgrastim; Fostamatinib Disodium Hexahydrate; inFLIXimab; Lecanemab; Maralixibat Chloride; Mavacamten; Nivolumab and Relatlimab; Norepinephrine Bitartate; Raltegravir Potassium; Ravulizumab; Relugolix, Estradiol, and Norethindrone Acetate; Retifanlimab; Setmelanotide Acetate; Sirolimus (Immunosuppressive Agent); Temsirolimus; Trofinetide; Vonoprazan.
Discontinued monographs: Abciximab; Anti-infectives Available from CDC; COVID-19 Vaccine (Janssen); Eflornithine; HYDROXYprogesterone; Immunization Schedules; Immunobiologic Agents Available from CDC; Measles, Mumps, and Rubella Vaccine; Mobocertinib; Vonoprazan, Clarithromycin, and Amoxicillin.
New MedWatch alerts on the following monographs: Semaglutide; Sotagliflozin.
13th February 2024
This update contains 11 new monographs, 24 revised monographs, and…
13th February 2024
This update contains 11 new monographs, 24 revised monographs, and 9 new MedWatch alerts.
New monographs: ADAMTS13, Recombinant-krhn; Capivasertib; Efbemalenograstim Alfa-vuxw; Fruquintinib; Ipratropium Bromide (EENT); Iptacopan Hydrochloride; levOCARNitine; Meningococcal Groups A, B, C, W, and Y Vaccine; Nirogacestat Hydrobromide; Repotrectinib; Zilucoplan Sodium.
Revised monographs: Alpelisib; Amifampridine Phosphate; Ansuvimab-zykl; Atazanavir Sulfate; Atoltivimab, Maftivimab, and Odesivimab-ebgn; Avalglucosidase Alfa-ngpt; Axitinib; Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide Fumarate; Cladribine (Immunomodulatory Agent); Denosumab; Doravirine; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate; Entecavir; Fosdenopterin Hydrobromide; Futibatinib; Lenalidomide; Lumasiran Sodium; Ocrelizumab; Pasireotide; Pegcetacoplan; Siponimod Fumarate; Teprotumumab-trbw; Tezepelumab-ekko; Vibegron.
New MedWatch alerts on the following monographs: Axicabtagene Ciloleucel; Brexucabtagene Autoleucel; Ciltacabtagene Autoleucel; cloBAZam; Eflornithine; Idecabtagene Vicleucel; LevETIRAcetam; Lisocabtagene Maraleucel; Tisagenlecleucel.
9th January 2024
This update contains 9 new monographs, 31 revised monographs, and…
9th January 2024
This update contains 9 new monographs, 31 revised monographs, and 2 new MedWatch alerts.
New monographs: Bimekizumab-bkzx; Etrasimod Arginine; Gepirone Hydrochloride; Mirikizumab-mrkz; Nedosiran Sodium; Phentolamine Mesylate; Tenapanor Hydrochloride (Phosphate-removing Agent); Toripalimab-tpzi; Vamorolone.
Revised monographs: Afamelanotide Acetate; AHFS Drug Information® Users Guide; Berotralstat Dihydrochloride; Dabrafenib Mesylate; Editorial Staff; Epoetin Alfa; Finerenone; Ibalizumab-uiyk; Icatibant Acetate; Ixekizumab; Mercaptopurine; Nirsevimab-alip; Notices; Ozanimod Hydrochloride; Pegfilgrastim; Preface; Rifamycin Sodium; Sargramostim; Spesolimab-sbzo; SUFentanil Citrate; Sutimlimab-jome; Tebentafusp-tebn; Tirzepatide; Tremelimumab-actl; Trientine; Trifarotene; Trilaciclib Dihydrochloride; Ustekinumab; Vedolizumab; Viloxazine Hydrochloride; Zuranolone.
New MedWatch alerts on the following monographs: COVID-19 Vaccine, mRNA (Moderna); Insulin Detemir.
5th December 2023
This update contains 11 new monographs, 20 revised monographs and…
5th December 2023
This update contains 11 new monographs, 20 revised monographs and 2 new MedWatch alerts.
New monographs: Albuterol Sulfate and Budenoside; Betibeglogene Autotemcel; Brexucabtagene Autoleucel; Cipaglucosidase Alfa-atga; Elivaldogene Autotemcel; Miglustat (Pompe Disease); Niraparib Tosylate and Abinoserone Acetate; Onasemnogene Abeparvovec-xioi; Sipuleucel-t; Voretigene Neparvovec-rzyl; Zuranolone.
Revised monographs: Argatroban; Bupivacaine and Meloxicam; COVID-19 Vaccine, mRNA (Moderna); COVID-19 Vaccine, mRNA (Pfizer-BioNTech); Dulaglutide; Edaravone; Enfuvirtide; Exenatide; Influenza Vaccine Live Intranasal; Influenza Vaccine Recombinant; Liraglutide; Lixisenatide; Maraviroc; Mitapivat sulfate; Propofol; Rilpivirine Hydrochloride; Risankizumab-rzaa; Ruxolitinib Phosphate; Semaglutide; Talimogene Laherparepvec.
New MedWatch alerts on the following monographs: Ketamine Hydrochloride; Mobocertinib Succinate.
14th November 2023
This update contains 11 new monographs, and 35 revised monographs…
14th November 2023
This update contains 11 new monographs, and 35 revised monographs
New monographs: Ciltacabtagene Autoleucel; Delandistrogene Moxeparvovec-rokl; Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol Trifenatate; Lisocabtagene Maraleucel; Momelotinib Dihydrochloride; Motixafortide Acetate; Nadofaragene Firadenovec-vncg; Palovarotene; Pozelimab-bbfg; Tisagenlecleucel; Umeclidinium Bromide and Vilanterol Trifenatate.
Revised monographs: Anifrolumab-fnia; Antihemophilic Factor (Recombinant), Fc fusion protein; Apremilast; Bempedoic Acid; Bupropion; Cabotegravir; Cephalosporins General Statement; Cladribine; Clascoterone; Crizanlizumab-tmca; Darolutamide; Dasatinib; Dimethyl Fumarate; Diroximel Fumarate; Efgartigimod Alfa-fcab; Emicizumab-kxwh; Fedratinib Hydrochloride ; Fluticasone Furoate and Vilanterol Trifenatate; Inclisiran Sodium; Ixazomib Citrate; Lenacapavir Sodium; Methoxy Polyethylene Glycol-epoetin Beta; Nilotinib; Osimertinib Mesylate; Peginterferon Beta-1a; PONATinib; Remdesivir; Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine, Adjuvanted; rifAXIMin; Selpercatinib; Sotorasib; Tirbanibulin; traMADol Hydrochloride; Tucatinib.
10th October 2023
This update contains 11 new monographs, 22 revised monographs, and…
10th October 2023
This update contains 11 new monographs, 22 revised monographs, and 4 new MedWatch alerts.
New monographs: Avacincaptad Pegol Sodium; Axicabtagene Ciloleucel; Cantharidin; Donislecel-jujn; Elranatamab-bcmm; Lotilaner; Nirsevimab-alip; Quizartinib Dihydrochloride; Rozanolixizumab-noli; Somatrogon-ghla; Talquetamab-tgvs.
Revised monographs: Abemaciclib; C1-Esterase Inhibitor (Human); C1-Esterase Inhibitor (Recombinant); Cabotegravir and Rilpivirine; Capmatinib Hydrochloride; Celecoxib; Dacomitinib; Deferiprone; Ebola Zaire Vaccine Live; Entrectinib; Evinacumab-dgnb; Ganaxolone; Gilteritinib Fumarate; Melphalan; Mepolizumab; Naloxone Hydrochloride; Olipudase alfa-rpcp; Omadacycline Tosylate; Pacritinib Citrate; Sodium Phenylbutyrate and Taurursodiol; Teclistamab-cqyv; Umeclidinium Bromide.
New MedWatch alerts on the following monographs: Bupivacaine Hydrochloride, Bupivacaine Liposomal; Chloroprocaine Hydrochloride; cloNIDine; Ropivacaine Hydrochlorid.
Access AHFS Drug Information through MedicinesComplete today.
Contact us now for pricing and access information.
$110.00
Info$99.00
Info$79.00
InfoSee all our printed publications in the Shop.
Instant online access to our essential knowledge 24/7
The Royal Pharmaceutical Society’s official journal
Trusted knowledge and revision for tomorrow’s pharmacists
High impact research in pharmaceutical sciences